Loading story…
Implantable neural devices and brain-computer interfaces are introducing a new class of cybersecurity and privacy risks, according to Professor Kevin Fu, director of the Archimedes Center for Health Care and Medical Device Cybersecurity at Northeastern University. These devices, which can include drug pumps and electrical therapies for neurological conditions, store highly sensitive neural data and are increasingly using sensors and AI to adapt therapies automatically, raising concerns about data protection and privacy engineering. The complexity of securing these devices is heightened by their limited battery power and the critical nature of the data they process.
Research at the Archimedes Center, supported by substantial funding, is focused on addressing these challenges and ensuring that privacy is built into the engineering of implantable medical technologies. As these devices become more advanced and widely used, ensuring robust cybersecurity measures and privacy protections is essential to safeguard patient data and prevent potential exploitation or misuse of neural information.
See the actors and campaigns active against you right now.
2 events from the most recent confirmed update back to the earliest known activity.
Professor Kevin Fu publicly warned that implantable neural devices and brain-computer interfaces create significant cybersecurity and privacy challenges because of the sensitivity of neural data, device power constraints, and the critical therapies they deliver. He also noted ongoing research, regulatory work, and the effect of U.S. Department of Health and Human Services changes on FDA cybersecurity collaboration with the medtech industry.
Northeastern University's Archimedes Center for Health Care and Medical Device Cybersecurity launched a new fellowship program aimed at improving hospital cybersecurity and vulnerability management. The references do not provide a more specific launch date.
See the adversaries and campaigns active against your sector right now, ranked by what they're exploiting.
2 references tracked. Mallory keeps watching after this page renders.
Map indicators from this story to your assets and identify affected systems in minutes.
Every observed campaign, victim, and pivot linked to actors named in this story.
Malware, exploits, and IOCs connected to the activity described here.
YARA, Sigma, and Snort rules deployed to your SIEM as soon as they’re published.
Get matching new stories delivered to your team as they break — not the next morning.
Ask questions about this story and take action on the answers.
Other stories Mallory is tracking that overlap on entities, sources, or topic labels.
AI-driven healthcare tools are expanding rapidly, but legal and security protections for patient data often lag behind their clinical ambitions. Reporting highlighted that consumer-facing medical chatbots and AI health offerings from **OpenAI**, **Anthropic**, and **Google** may fall outside **HIPAA** obligations in many common use cases, meaning sensitive health information shared with these services may not receive the same statutory protections as data handled by regulated healthcare providers; experts warned that terms-of-service promises are not equivalent to regulated safeguards and that non-HIPAA consumer health data can be sold or shared with third parties, including data brokers. Separately, an investigation summarized from Reuters described patient-safety concerns tied to “AI-enhanced” medical devices, citing lawsuits and FDA adverse-event reporting that allege AI-related changes contributed to serious surgical injuries. One example involved an AI-updated sinus surgery navigation system where reported malfunctions increased sharply after an AI “enhancement,” though the reporting noted FDA incident data is incomplete and does not by itself prove causation; the same coverage also pointed to a higher recall rate for FDA-authorized medical AI devices versus baseline and described FDA capacity constraints in reviewing AI-enabled devices due to staffing losses in relevant technical teams.
Jun 29, 2026
Healthcare organizations face increasing cybersecurity threats as both medical transportation providers and telehealth setups adopt digital technologies. Non-emergency medical transportation (NEMT) companies, which handle sensitive patient data through scheduling, billing, and mobile dispatch systems, are now high-value targets for cybercriminals. The digitization of these services, combined with remote work and cloud-hosted tools, expands the attack surface, making patient records vulnerable to ransomware and data breaches. Each connected device, from vehicles to smartphones, represents a potential entry point for attackers seeking to exploit HIPAA-protected information. Similarly, the integration of smart speakers and IoT devices into home healthcare environments introduces new risks, such as data exfiltration, manipulation, and unauthorized access. The National Institute of Standards and Technology (NIST) has issued guidelines to address these challenges, recommending measures like encrypting communications, restricting device access, and implementing network segmentation to protect patient data. These safeguards are designed to help both healthcare providers and patients mitigate the risks associated with connected medical devices and ensure the privacy and security of sensitive health information.
Jul 12, 2026
Healthcare providers and health IT vendors are increasingly adopting artificial intelligence (AI) tools, such as AI assistants, to enhance patient access to electronic health records. The Department of Health and Human Services (HHS) is actively promoting initiatives to improve interoperability between digital health platforms and applications, aiming to make it easier for patients to access and understand their health information. One such initiative, 'Make Health Technology Great Again,' encourages the development and use of third-party patient applications, including conversational AI assistants, to provide patients with more personalized insights and support better health decisions. However, the integration of AI into patient data access workflows introduces significant data privacy and security challenges. Providers must ensure that electronic health information is securely transmitted among multiple healthcare organizations, maintaining compliance with regulatory requirements. Attorney Alisa Chestler of Baker Donelson highlights the need for healthcare entities to balance the benefits of AI-enabled access with the risks of unauthorized data exposure and potential breaches. Regulatory considerations are evolving as agencies like HHS emphasize both patient empowerment and the safeguarding of sensitive health data. The use of AI in this context raises concerns about data sharing, consent management, and the potential for misuse of personal health information. Healthcare organizations are urged to implement robust security measures, including encryption and access controls, to mitigate risks associated with AI-driven data access. The legal landscape is also shifting, with new guidelines and enforcement actions expected to address emerging threats. Vendors developing AI health applications must prioritize privacy-by-design principles and ensure transparency in data handling practices. The conversation around AI and patient data access is further complicated by the need for interoperability, which can increase the attack surface for malicious actors. Stakeholders are advised to stay informed about regulatory updates and best practices for securing AI-enabled health data systems. The ongoing dialogue between regulators, providers, and technology vendors is critical to achieving a balance between innovation and security. Ultimately, the adoption of AI in healthcare data access presents both opportunities for improved patient outcomes and challenges in maintaining data integrity and confidentiality.
Jun 29, 2026